• LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn

R.D. Solorzano

  • Vensana Capital Unveils Vensana Innovation, Welcomes Dr. Thomas Tu as Venture Partner
    October 8, 2025

    Vensana Capital Unveils Vensana Innovation, Welcomes Dr. Thomas Tu as Venture Partner

    R.D. Solorzano
  • Tides Medical – APLICOR 3D’s  New Personalized 3D Bioprinted Skin Graft Available for Patients at Singing River Health System
    October 7, 2025

    Tides Medical – APLICOR 3D’s New Personalized 3D Bioprinted Skin Graft Available for Patients at Singing River Health System

    R.D. Solorzano
  • NIH Launches Nation’s First Dedicated Organoid Development Center
    October 3, 2025

    NIH Launches Nation’s First Dedicated Organoid Development Center

    R.D. Solorzano
  • CUTISS Secures CHF 56 Million Series C to Advance Phase 3 Skin-Tissue Therapy
    September 29, 2025

    CUTISS Secures CHF 56 Million Series C to Advance Phase 3 Skin-Tissue Therapy

    R.D. Solorzano
  • MIT and Polimi Develop Low-Cost AI Monitoring System to Improve 3D Bioprinting of Engineered Tissues
    September 25, 2025

    MIT and Polimi Develop Low-Cost AI Monitoring System to Improve 3D Bioprinting of Engineered Tissues

    R.D. Solorzano
  • Prellis Biologics and Eli Lilly Sign Multi-Target Antibody Discovery Agreement
    September 23, 2025

    Prellis Biologics and Eli Lilly Sign Multi-Target Antibody Discovery Agreement

    R.D. Solorzano
  • Humacyte Reports Positive Data on Bioengineered Vessels for Vascular Repair and Coronary Bypass
    September 22, 2025

    Humacyte Reports Positive Data on Bioengineered Vessels for Vascular Repair and Coronary Bypass

    R.D. Solorzano
  • eGenesis Wins FDA Green Light for Gene-Edited Pig Kidney Trial
    September 22, 2025

    eGenesis Wins FDA Green Light for Gene-Edited Pig Kidney Trial

    R.D. Solorzano
  • Tel Aviv University and Matricelf Poised for First-in-Human Spinal Cord Implant
    September 12, 2025

    Tel Aviv University and Matricelf Poised for First-in-Human Spinal Cord Implant

    R.D. Solorzano
  • Terumo Acquires OrganOx for $1.5 Billion: A Landmark Deal in Organ Preservation and Transplantation
    August 25, 2025

    Terumo Acquires OrganOx for $1.5 Billion: A Landmark Deal in Organ Preservation and Transplantation

    R.D. Solorzano
Previous Page
1 2 3 4 5 … 12
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar